Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pain, Postoperative × Therapeutics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 46 Neoplasms 43 Depression 31 Fatigue 29 Prostatic Neoplasms 22 Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Lymphoma, Follicular 18 Multiple Myeloma 16 Lymphoma, Large B-Cell, Diffuse 16 Carcinoma, Non-Small-Cell Lung 16 Lymphoma, Non-Hodgkin 15 Lung Neoplasms 15 Leukemia, Lymphocytic, Chronic, B-Cell 15 Lymphoma, Mantle-Cell 14 Leukemia, Myeloid, Acute 14 Hodgkin Disease 14 Colorectal Neoplasms 14 Burkitt Lymphoma 14 Anxiety Disorders 14 Pain 13 Lymphoma, B-Cell, Marginal Zone 13 Lymphoma, Large-Cell, Immunoblastic 12 Lymphoma 11 Leukemia, Myeloid, Chronic-Phase 11 Head and Neck Neoplasms 11 Blast Crisis 11 Lymphoma, T-Cell, Cutaneous 10 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 10 Leukemia, Myeloid, Accelerated Phase 10 Leukemia, Hairy Cell 10

Interventions

Bupivacaine 32 Dexmedetomidine 19 Saline Solution 18 Ropivacaine 18 Morphine 12 Ketamine 12 Sodium Chloride 10 Acetaminophen 10 Pregabalin 9 Lidocaine 9 Control Groups 9 Injections, Epidural 5 Dexamethasone 5 Surgical Procedures, Operative 4 Gabapentin 4 Epinephrine 4 Anesthetics, Local 4 Anesthesia, General 4 Analgesia, Patient-Controlled 4 parecoxib 3 oxycodone-acetaminophen 3 Tea 3 Midazolam 3 Ketorolac 3 Fentanyl 3 Esketamine 3 Dental Occlusion 3 Anti-Inflammatory Agents, Non-Steroidal 3 Analgesics, Opioid 3 Vitamins 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04518085 2023-12-08

PREVENT

University of Oslo

Phase NA Completed

Data powered by HemOnc (CC BY 4.0) Colophon ⚡